Dr. Pena studies a wide range of medical conditions and treatments, with a significant emphasis on the development of new antiviral compounds aimed at treating COVID-19. His research has led to the discovery of compounds that effectively block the virus responsible for the pandemic. Additionally, he investigates diagnostic tools for conditions such as pancreatic cystic lesions and colorectal cancer, improving methods to identify threats like tumors through advanced biopsy techniques. Dr. Pena is also concerned with the genetic factors of diseases, exploring how specific gene mutations contribute to skeletal disorders and other health issues. His work not only focuses on medical treatments but also emphasizes environmental aspects, like converting waste paper into beneficial biochar to reduce greenhouse gas emissions.
Key findings
Dr. Pena's study found that two antiviral compounds blocked over 90% of SARS-CoV-2, with one compound showing effective results at 31 nanomoles per liter.
In assessing pancreatic cystic lesions, fine-needle biopsy (FNB) successfully diagnosed 81% of cases, nearly double the effectiveness of fine-needle aspiration (FNA), which had a 62% success rate.
For patients with inherited genetic mutations, 44% were found to have adenomas, significantly higher than the general population's rate, highlighting the need for proactive screenings.
Frequently asked questions
Does Dr. Pena study COVID-19?
Yes, Dr. Pena researches antiviral compounds specifically aimed at treating COVID-19.
What treatments has Dr. Pena researched for pancreatic cancer?
He has investigated fine-needle biopsy techniques, which have proven to be highly effective in diagnosing pancreatic cystic lesions, a precursor to pancreatic cancer.
Is Dr. Pena's work relevant to patients with heart diseases?
Yes, he examines conditions like endomyocardial fibrosis, a tropical heart disease affecting young people, highlighting the need for better diagnosis and treatment.
Publications in plain English
Novel antiviral compounds: Synthesis, biological studies on SARS-CoV-2, and structure-activity relationship analysis.
2026
Bioorganic & medicinal chemistry
Kumar S, Mendes RPG, Bansal M, Upadhyay C, Dantas WM +8 more
Plain English This study explored the effectiveness of 28 new antiviral compounds against SARS-CoV-2, the virus that causes COVID-19. Researchers found that two compounds, 3d and 3f, blocked over 90% of the virus, with compound 3f being particularly potent at a concentration of 31 nanomoles per liter and showing low toxicity to cells. Although compound 3f is promising for treating COVID-19, it breaks down quickly in the body, indicating a need for further development to improve its stability.
Who this helps: This benefits patients and healthcare providers looking for effective treatments for COVID-19.
Upconversion of non-recycled MSW paper fractions into biochar via slow pyrolysis and life cycle analysis: Pathways to net negative GHG emission.
2026
Journal of environmental management
Rao R, Pena L, Haque N, Salas M, Bera S +3 more
Plain English This study looked at how to turn non-recycled paper waste from cities into a valuable product called biochar, which can help fight climate change. Researchers found that the biochar made from the paper waste has a high carbon content of up to 76.9%, significantly reducing greenhouse gas emissions, with a net carbon removal of -427.36 kg per ton of paper waste processed. This is important because it offers a way to reduce waste and emissions far more than traditional methods, like landfilling, which causes pollution.
Who this helps: This helps communities and environmental groups focused on reducing waste and greenhouse gas emissions.
Why genetic testing is important in patients with developmental disabilities-a unique case of progressive hypertonia and chorea: VARS2-related disorder.
2025
PM & R : the journal of injury, function, and rehabilitation
Strader S, Vawter-Lee M, Pena L, Huxol H, Harris C
Influenza virus: Genomic insights, evolution, and its clinical presentation.
2025
Microbial pathogenesis
Jain R, Sharma H, Pena L, Jit S, Rathi B +2 more
Plain English This study looked at the influenza virus, which causes seasonal outbreaks that infect millions of people each year and result in hundreds of thousands of deaths. It highlighted that certain proteins in the virus change frequently, making it hard to keep vaccines and treatments up to date. Understanding the virus's genetic makeup and how it evolves can help create better medicines and a universal vaccine, making future outbreaks less severe.
Who this helps: This helps patients, doctors, and public health officials in managing influenza effectively.
Choice architecture in cascade genetic testing (CHARGE study) for hereditary cancer: Design of a hybrid type I randomized feasibility trial.
2025
Contemporary clinical trials
Makhnoon S, Getchell G, Rodriguez Y, Pena L, Rodriguez J +5 more
Plain English This study looked at ways to improve the rate of genetic testing for cancer in people who have relatives at risk but haven't been tested. It compared a new approach that makes testing easier, including offering free tests and support, with the usual care approach. The goal is to see if these changes lead to more people getting tested, as past studies showed low testing rates due to poor family communication and high costs.
Who this helps: This benefits patients with hereditary cancer risks and their families.
Assessing outcomes of full-thickness resection in piecemeal polypectomy scar consolidation of colon adenomas containing cancer.
2025
Endoscopy international open
Radosavljevic I, Dam A, Luthra AK, Pena L, Cappelle S +6 more
Plain English This study looked at a new method called endoscopic full thickness resection (EFTR) for removing cancerous cells from polyp scars in the colon, which usually requires traditional surgery. Out of 14 patients, the procedure was 100% technically successful, and 14% had leftover cancer cells after the treatment. One patient needed further surgery, but all others showed no malignancy afterward, and there was only one minor complication.
Who this helps: This benefits patients with cancerous colorectal polyps by providing a less invasive treatment option.
Premalignant Colorectal Adenoma Detection in Individuals with InheritedGenetic Mutations: A Single-Institution Experience.
2025
Southern medical journal
Shannon AB, Laronga C, Balsay-Patel C, Barton LV, Pena L +5 more
Plain English This study looked at patients with inherited genetic mutations to see how likely they are to develop precancerous growths in the colon, called adenomas. The researchers found that 44% of the patients had adenomas, which is much higher than in the general population, and among younger patients under 45, the detection rate was 50%. This matters because it shows that people with these mutations may need earlier and more frequent colon screenings to catch these growths early.
Who this helps: This benefits patients with inherited genetic mutations and their healthcare providers.
Evidence-based classification of genes implicated in skeletal disorders using the ClinGen curation framework.
2025
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Webb RF, McCurry H, Girod A, Hughes M, Wilcox E +23 more
Plain English This study looked at the relationship between specific genes and skeletal disorders, analyzing nine key genes linked to 26 different conditions. The researchers found that 84.6% of these relationships were classified as "Definitive," meaning there is strong evidence these genes cause skeletal diseases. This is important because it can help improve genetic testing, making it easier for doctors to diagnose these disorders accurately.
Who this helps: This helps patients with skeletal disorders and their doctors.
Plain English This study looked at the best nursing practices for caring for people with mental disorders in emergency situations before they reach the hospital. Researchers reviewed 4,184 publications and found 23 relevant studies, highlighting four key areas of care, which included safety, assessment, management, and the use of restraints. They emphasized the importance of preventing risks, communicating effectively, managing behavior, and providing support during suicidal emergencies.
Who this helps: This helps patients with mental disorders and the healthcare professionals who care for them.
Endoscopic ultrasound-guided fine-needle biopsy as a novel approach for risk stratification of pancreatic cystic lesions.
2025
iGIE : innovation, investigation and insights
Moussavi GH, Gomez MF, Permuth J, Dam A, Luthra AK +5 more
Plain English This study looked at two methods for diagnosing pancreatic cystic lesions (PCLs): fine-needle aspiration (FNA) and fine-needle biopsy (FNB). The researchers found that FNB provided better results, successfully diagnosing 81% of cases compared to 62% with FNA, making it nearly twice as effective at identifying a specific type of cyst known as intraductal papillary mucinous neoplasm (IPMN). This matters because a more accurate diagnosis can lead to better treatment decisions for patients with these cysts.
Who this helps: Patients with pancreatic cystic lesions.
A Narrative Review on Endomyocardial Fibrosis: Unraveling an Under-Recognized Tropical Heart Disease.
2025
Cureus
Adhikari S, Ibrahim D, Kothakapa SL, Pena L, Barsinge T +6 more
Plain English This study looks at endomyocardial fibrosis (EMF), a serious heart disease mainly affecting children in poorer tropical areas. The researchers found that EMF causes heart problems like heart failure and valve issues, and it is often diagnosed late because the symptoms can be mistaken for other conditions. These findings emphasize the need for better awareness and resources to help those suffering from this neglected disease.
Who this helps: This helps patients with EMF and healthcare providers treating them.
Development and field validation of a reverse transcription loop-mediated isothermal amplification assay (RT-LAMP) for the rapid detection of chikungunya virus in patient and mosquito samples.
2024
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Silva SJRD, Magalhães JJF, Matthews Q, Divarzak ALL, Mendes RPG +6 more
Plain English This study focused on creating a fast and effective test to detect the chikungunya virus in human and mosquito samples from Brazil. Researchers developed a new testing method called RT-LAMP that can accurately identify the virus in just 20-30 minutes with a clinical sensitivity of 100% and a specificity of nearly 97%. This test is significant because it makes it easier to diagnose chikungunya quickly in areas with limited resources.
Who this helps: This benefits patients, doctors, and public health officials, especially in low- and middle-income countries.
Induced pluripotent stem cell (iPSC) modeling validates reduced GBE1 enzyme activity due to a novel variant, p.Ile694Asn, found in a patient with suspected glycogen storage disease IV.
2024
Molecular genetics and metabolism reports
Naito C, Kosar K, Kishimoto E, Pena L, Huang Y +8 more
Plain English This study focused on a patient with Glycogen Storage Disease type 4 (GSD4), which results from a shortage of a specific enzyme called GBE1. Researchers discovered a new mutation in the GBE1 gene that reduced enzyme activity, showing that both liver and heart cells from this patient had lower enzyme levels and accumulated harmful substances typical of the disease. This is important because accurately identifying the genetic cause of GSD4 can help prevent complications from treatments like liver transplants.
Who this helps: This research helps patients with GSD4 by improving diagnosis and treatment strategies.
Influence of Stress Severity on Contextual Fear Extinction and Avoidance in a Posttraumatic-like Mouse Model.
2024
Brain sciences
Eyraud N, Bloch S, Brizard B, Pena L, Tharsis A +3 more
Plain English This study looked at how different levels of stress affect fear and behavior in mice that were trained to associate a specific environment with a traumatic event, similar to post-traumatic stress disorder (PTSD) in humans. The researchers found that mice who experienced more stress showed stronger fear responses and avoided reminders of the scary event, even after they had been trained to overcome their fear. This is important because it helps us understand the lasting impacts of trauma and can lead to better treatments for PTSD in humans.
Who this helps: This helps patients with PTSD and their doctors by providing insights for improving treatment strategies.
Rationale for Hepatitis C Virus Treatment During Hematopoietic Stem Cell Transplant in the Era of Novel Direct-Acting Antivirals.
2024
Digestive diseases and sciences
Makovich Z, Radosavljevic I, Chapyala S, Handley G, Pena L +2 more
Plain English This study examined the effects of untreated hepatitis C (HCV) infection on patients undergoing hematopoietic stem cell transplantation (HSCT) and whether treating HCV during the transplant process is safe. Researchers found that HCV can worsen outcomes, potentially leading to severe complications like increased mortality, but using newer antiviral medications during HSCT could be effective. Specifically, medications such as sofosbuvir/velpatasvir and glecaprevir/pibrentasvir show promise for treating HCV in these patients.
Who this helps: This benefits patients undergoing stem cell transplants who also have hepatitis C.
Elevated Urinary Levels of Fungal and Environmental Toxins in Patients with Pancreatic Ductal Adenocarcinoma.
2024
Journal of gastrointestinal cancer
Rodriguez VI, Mammadova J, Permuth JB, Luthra A, Pena L +7 more
Plain English This study looked at the levels of certain toxins in the urine of patients with pancreatic ductal adenocarcinoma (PDAC) compared to healthy individuals. Researchers found that PDAC patients had significantly higher levels of fungal toxins, like ochratoxin and gliotoxin, and environmental toxins such as xylene and perchlorate, with a p-value of less than 0.05 indicating strong results. This matters because understanding these toxin levels could help identify new risk factors for developing PDAC, leading to better prevention strategies.
Who this helps: This research benefits patients at risk for pancreatic cancer and doctors seeking to improve screening and prevention methods.
Correction: Comparison of DNA extraction methods for COVID-19 host genetics studies.
2024
PloS one
Silva RCD, de Lima SC, Dos Santos Reis WPM, de Magalhães JJF, de Oliveira RN +4 more
Plain English This study looked at different ways to extract DNA for researching the genetics of people affected by COVID-19. The researchers compared several DNA extraction methods and found that one technique was 30% more efficient than the others. This matters because getting good DNA samples is crucial for understanding how genetics influence COVID-19 outcomes.
Who this helps: This helps researchers studying COVID-19 and its effects on different individuals.
Clinical and laboratory diagnosis of monkeypox (mpox): Current status and future directions.
2023
iScience
Silva SJRD, Kohl A, Pena L, Pardee K
Plain English This study focused on monkeypox, a virus that is spreading rapidly to countries where it hasn't been seen before. Researchers found that diagnosing monkeypox can be tough because its symptoms can look like other skin conditions. They reviewed the types of laboratory tests available for accurately identifying the virus and discussed how these tests can help manage and respond to monkeypox, especially in countries with fewer resources.
Who this helps: This research benefits doctors and healthcare providers involved in diagnosing and treating monkeypox.
An autosomal-dominant childhood-onset disorder associated with pathogenic variants in VCP.
2023
American journal of human genetics
Mah-Som AY, Daw J, Huynh D, Wu M, Creekmore BC +30 more
Plain English This study focused on a genetic disorder caused by changes in a gene called VCP, which usually leads to problems later in life. Researchers found that 13 children with specific VCP changes showed symptoms like developmental delays, intellectual disabilities, and larger head sizes. They discovered that many of these gene changes reduced the protein's activity, suggesting a different reason for the children's health issues compared to those seen in older patients with VCP-related disorders.
Who this helps: This benefits children with developmental disorders tied to genetic changes in VCP and their families.
Comparison of DNA extraction methods for COVID-19 host genetics studies.
2023
PloS one
Silva RCD, de Lima SC, Dos Santos Reis WPM, de Magalhães JJF, Magalhães RNO +4 more
Plain English This study looked at different methods for extracting DNA from samples taken from COVID-19 patients to understand how genetics affects disease outcomes. Researchers tested three techniques and found that the Chelex®100 method was not only the cheapest—up to 33 times less expensive than the other methods—but also produced the most DNA, yielding 306 times more than the commercial kit. This discovery is important because it allows for better and more affordable genetic studies, particularly in developing countries where resources are limited.
Who this helps: Patients and researchers in developing countries.
Brijesh Rathi Mark Friedman Alain Kohl Aamir Dam Saraswathi Cappelle Jurandy Júnior Ferraz de Magalhães Renata Pessôa Germano Mendes Ronaldo Nascimento de Oliveira Anjuli K Luthra Shaffer R S Mok
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.